Potassium Chloride in Dextrose and Sodium Chloride

Manufacturer
ICU Medical Inc.
Effective date
2025-11-02
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
18
Source
monthly-update
Hydrated at
2026-07-17 21:38:14

Label at a glance#

ProductPotassium Chloride in Dextrose and Sodium Chloride
Active ingredientDEXTROSE MONOHYDRATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE
Label structure20 sections

Indications and uses

These solutions are indicated in patients requiring parenteral administration of potassium chloride with minimal carbohydrate calories and sodium chloride.

Dosage and administration

These solutions should be administered only by intravenous infusion and as directed by the physician. The dose and rate of injection are dependent upon the age, weight and clinical condition of the patient. If the serum potassium level is greater than 2.5 mEq/liter, potassium should be given at a rate not to exceed 10 mEq/hour in a concentration less than 30 mEq/liter. Somewhat faster rates and greater concentrati...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx only

Potassium Chloride in 5% Dextrose and Sodium Chloride Injection, USP

Flexible Plastic Container

DESCRIPTION

DESCRIPTION SECTION

Intravenous solutions with potassium chloride (I.V. solutions with KCl) are sterile and nonpyrogenic solutions in water for injection. They are for administration by intravenous infusion only.

See Tables for summary of content and characteristics of these solutions.

The solutions contain no bacteriostat, antimicrobial agent or added buffer and each is intended only for use as a single-dose injection. When smaller doses are required the unused portion should be discarded.

These solutions are parenteral fluid, nutrient and/or electrolyte replenishers.

Dextrose, USP is chemically designated D-glucose, monohydrate (C6H12O6 • H2O), a hexose sugar freely soluble in water. It has the following structural formula:

structural formula dextrosestructural formula dextrose

Potassium Chloride, USP is chemically designated KCl, a white granular powder freely soluble in water.

Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water.

Water for Injection, USP is chemically designated H2O.

The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C/77°F during transport and storage will lead to minor losses in the moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

When administered intravenously, these solutions provide a source of water and potassium chloride with carbohydrate (dextrose) and sodium chloride. See HOW SUPPLIED section for specific concentrations of these various solutions.

Solutions containing carbohydrate in the form of dextrose restore blood glucose levels and provide calories. Carbohydrate in the form of dextrose may aid in minimizing liver glycogen depletion and exerts a protein-sparing action. Dextrose injected parenterally undergoes oxidation to carbon dioxide and water.

Intravenous solutions containing potassium chloride are particularly intended to provide needed potassium cation (K+). Potassium is the chief cation of body cells (160 mEq/liter of intracellular water). It is found in low concentration in plasma and extracellular fluids (3.5 to 5.0 mEq/liter in a healthy adult). Potassium plays an important role in electrolyte balance. Normally about 80 to 90% of the potassium intake is excreted in the urine; the remainder in the stools and to a small extent, in the perspiration. The kidney does not conserve potassium well so that during fasting or in patients on a potassium-free diet, potassium loss from the body continues resulting in potassium depletion. A deficiency of either potassium or chloride will lead to a deficit of the other.

Sodium chloride in water dissociates to provide sodium (Na+) and chloride (Cl−) ions. Sodium (Na+) is the principal cation of the extracellular fluid and plays a large part in the therapy of fluid and electrolyte disturbances. Chloride (Cl−) has an integral role in buffering action when oxygen and carbon dioxide exchange occurs in the red blood cells. The distribution and excretion of sodium (Na+) and chloride (Cl−) are largely under the control of the kidney which maintains a balance between intake and output.

Water is an essential constituent of all body tissues and accounts for approximately 70% of total body weight. Average normal adult daily requirement ranges from two to three liters (1.0 to 1.5 liters each for insensible water loss by perspiration and urine production).

Water balance is maintained by various regulatory mechanisms. Water distribution depends primarily on the concentration of electrolytes in the body compartments and sodium (Na+) plays a major role in maintaining physiologic equilibrium.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

These solutions are indicated in patients requiring parenteral administration of potassium chloride with minimal carbohydrate calories and sodium chloride.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Solutions containing potassium chloride are contraindicated in diseases where high potassium levels may be encountered.

WARNINGS

WARNINGS SECTION

Solutions which contain potassium ions should be used with great care, if at all, in patients with hyperkalemia, severe renal failure and in conditions in which potassium retention is present.

To avoid potassium intoxication, do not infuse these solutions rapidly. In patients with severe renal insufficiency or adrenal insufficiency, administration of potassium chloride may cause potassium intoxication.

Solutions containing sodium ions should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency and in clinical states in which there exists edema with sodium retention.

In patients with diminished renal function, administration of solutions containing sodium or potassium ions may result in sodium or potassium retention.

The intravenous administration of these solutions can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema.

The risk of dilutional states is inversely proportional to the electrolyte concentration of administered parenteral solutions. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of such solutions.

PRECAUTIONS

PRECAUTIONS SECTION

Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.

Solutions containing dextrose should be used with caution in patients with known subclinical or overt diabetes mellitus.

Caution must be exercised in the administration of parenteral fluids, especially those containing sodium ions, to patients receiving corticosteroids or corticotropin.

Potassium replacement therapy should be guided primarily by serial electrocardiograms. Plasma potassium levels are not necessarily indicative of tissue potassium levels.

High plasma concentrations of potassium may cause death through cardiac depression, arrhythmias or arrest.

Potassium-containing solutions should be used with caution in the presence of cardiac disease, particularly in digitalized patients or in the presence of renal disease.

Care should be exercised to insure that the needle (or catheter) is well within the lumen of the vein and that extravasation does not occur.

Do not administer unless solution is clear and container is undamaged. Discard unused portion.

Carcinogenesis, Mutagenesis, Impairment of Fertility:

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Studies with solutions from flexible plastic containers have not been performed to evaluate carcinogenic potential, mutagenic potential or effects on fertility.

PREGNANCY SECTION

Pregnancy Category C. Animal reproduction studies have not been conducted with dextrose, potassium chloride or sodium chloride. It is also not known whether dextrose, potassium chloride or sodium chloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Dextrose, potassium chloride or sodium chloride should be given to a pregnant woman only if clearly needed.

Nursing Mothers:

NURSING MOTHERS SECTION

Caution should be exercised when solutions from flexible plastic containers are administered to a nursing mother.

Pediatric Use:

PEDIATRIC USE SECTION

The safety and effectiveness in the pediatric population are based on the similarity of the clinical conditions of the pediatric and adult populations. In neonates or very small infants the volume of fluid may affect fluid and electrolyte balance.

Frequent monitoring of serum glucose concentrations is required when dextrose is prescribed to pediatric patients, particularly neonates and low birth weight infants.

In very low birth weight infants, excessive or rapid administration of dextrose injection may result in increased serum osmolality and possible intracerebral hemorrhage.

Geriatric Use:

GERIATRIC USE SECTION

An evaluation of current literature revealed no clinical experience identifying differences in response between elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Sodium and potassium ions are known to be substantially excreted by the kidney, and the risk of toxic reactions may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Reactions which may occur because of the solutions or technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia.

If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.

Nausea, vomiting, abdominal pain and diarrhea have been reported with potassium therapy. The signs and symptoms of potassium intoxication include paresthesias of the extremities, flaccid paralysis, listlessness, mental confusion, weakness and heaviness of the legs, hypotension, cardiac arrhythmias, heart block, electrocardiographic abnormalities such as disappearance of P waves, spreading and slurring of the QRS complex with development of a biphasic curve and cardiac arrest.

Potassium-containing solutions are intrinsically irritating to tissues. Therefore, extreme care should be taken to avoid perivascular infiltration. Local tissue necrosis and subsequent sloughing may result if extravasation occurs. Chemical phlebitis and venospasm have also been reported.

Should perivascular infiltration occur, I.V. administration at that site should be discontinued at once. Local infiltration of the affected area with procaine hydrochloride, 1%, to which hyaluronidase may be added, will often reduce venospasm and dilute the potassium remaining in the tissues locally. Local application of heat may also be helpful.

OVERDOSAGE

OVERDOSAGE SECTION

In the event of potassium overdosage, discontinue the infusion immediately and institute intensive corrective therapy to reduce serum potassium levels. See WARNINGS and PRECAUTIONS.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

These solutions should be administered only by intravenous infusion and as directed by the physician. The dose and rate of injection are dependent upon the age, weight and clinical condition of the patient. If the serum potassium level is greater than 2.5 mEq/liter, potassium should be given at a rate not to exceed 10 mEq/hour in a concentration less than 30 mEq/liter. Somewhat faster rates and greater concentrations (usually up to 40 mEq/liter) of potassium may be indicated in patients with more severe potassium deficiency. The total 24-hour dose should not generally exceed 200 mEq of potassium.

As reported in the literature, the dosage and constant infusion rate of intravenous dextrose must be selected with caution in pediatric patients, particularly neonates and low birth weight infants, because of the increased risk of hyperglycemia/hypoglycemia.

Drug Interactions

DRUG INTERACTIONS SECTION

Additives may be incompatible. Consult with pharmacist, if available. When introducing additives, use aseptic technique, mix thoroughly and do not store.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. See PRECAUTIONS.

INSTRUCTIONS FOR USE

SPL UNCLASSIFIED SECTION

To Open

Tear outer wrap at notch and remove solution container. If supplemental medication is desired, follow directions below before preparing for administration. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually.

To Add Medication

  1. Prepare additive port.
  2. Using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. Withdraw needle after injecting medication.
  3. The additive port may be protected by covering with an additive cap.
  4. Mix container contents thoroughly.

Preparation for Administration

(Use aseptic technique)

  1. Close flow control clamp of administration set.
  2. Remove cover from outlet port at bottom of container.
  3. Insert piercing pin of administration set into port with a twisting motion until the set is firmly seated. NOTE: See full directions on administration set carton.
  4. Suspend container from hanger.
  5. Squeeze and release drip chamber to establish proper fluid level in chamber.
  6. Open flow control clamp and clear air from set. Close clamp.
  7. Attach set to venipuncture device. If device is not indwelling, prime and make venipuncture.
  8. Regulate rate of administration with flow control clamp.

WARNING: Do not use flexible container in series connections.

HOW SUPPLIED

HOW SUPPLIED SECTION

Intravenous solutions with potassium chloride (I.V. solution with KCl) are supplied in single-dose flexible plastic containers. See Tables:

TABLE 1
Potassium Chloride in 5% Dextrose and 0.225% Sodium Chloride Inj., USPCOMPOSITION (g/L)Approx. Ionic Concentrations (mEq/L)
mEq PotassiumSize (mL)Dextrose, HydrousSodium ChloridePotassium ChlorideCalculated Osmolarity (mOsmol/L)pHSodium (Na+)Potassium (K+)Chloride (Cl–)Approximate kcal/LNDC NO.
20 mEq1000502.251.493704.2
(3.5 to 6.5)
38.52058.51700409-7901-091
20 mEq1000502.251.493704.2
(3.5 to 6.5)
38.52058.51700990-7901-091

ICU Medical is transitioning NDC codes from the "0409" to a "0990" labeler code. Both NDC codes are expected to be in the market for a period of time.

TABLE 2
Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Inj., USPCOMPOSITION (g/L)Approx. Ionic Concentrations (mEq/L)
mEq PotassiumSize
(mL)
Dextrose, HydrousSodium ChloridePotassium ChlorideCalculated Osmolarity (mOsmol/L)pHSodium (Na+)Potassium (K+)Chloride (Cl–)Approximate kcal/LNDC NO.
10 mEq1000504.50.7454264.2
(3.5 to 6.5)
7710871700409-7993-092
10 mEq1000504.50.7454264.2
(3.5 to 6.5)
7710871700990-7993-091,2
10 mEq500504.51.494474.2
(3.5 to 6.5)
7720971700409-7902-032
10 mEq500504.51.494474.2
(3.5 to 6.5)
7720971700990-7902-031,2
20 mEq1000504.51.494474.2
(3.5 to 6.5)
7720971700409-7902-091,2
20 mEq1000504.51.494474.2
(3.5 to 6.5)
7720971700990-7902-091,2
30 mEq1000504.52.244674.2
(3.5 to 6.5)
77301071700409-7903-091
30 mEq1000504.52.244674.2
(3.5 to 6.5)
77301071700990-7903-091
40 mEq1000504.52.984874.2
(3.5 to 6.5)
77401171700409-7904-091,2
40 mEq1000504.52.984874.2
(3.5 to 6.5)
77401171700990-7904-091,2

ICU Medical is transitioning NDC codes from the "0409" to a "0990" labeler code. Both NDC codes are expected to be in the market for a period of time.

TABLE 3
Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Inj., USPCOMPOSITION (g/L)Approx. Ionic Concentrations (mEq/L)
mEq PotassiumSize
(mL)
Dextrose, HydrousSodium ChloridePotassium ChlorideCalculated Osmolarity (mOsmol/L)pHSodium (Na+)Potassium (K+)Chloride (Cl–)Approximate kcal/LNDC NO.
20 mEq10005091.496004.2
(3.5 to 6.5)
154201741700409-7107-092
20 mEq10005091.496004.2
(3.5 to 6.5)
154201741700990-7107-091,2
40 mEq10005092.986404.2
(3.5 to 6.5)
154401941700409-7109-092
40 mEq10005092.986404.2
(3.5 to 6.5)
154401941700990-7109-091,2

ICU Medical is transitioning NDC codes from the "0409" to a "0990" labeler code. Both NDC codes are expected to be in the market for a period of time.



May contain HCl for pH adjustment.


Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]

Protect from freezing.


Revised: December, 2020

1Manufactured by ICU Medical, Inc., Lake Forest, Illinois, 60045, USA
2Manufactured for ICU Medical, Inc., Lake Forest, Illinois, 60045, USA

IFU0000280

PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label - IMP0000044

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

20 mEq POTASSIUM

1000 mL

NDC 0990-7107-09

20
mEq

POTASSIUM
CHLORIDE

in 5% Dextrose and
0.9% Sodium Chloride
Injection, USP

EACH 100 mL CONTAINS POTASSIUM
CHLORIDE 149 mg; SODIUM CHLORIDE
900 mg; DEXTROSE, HYDROUS 5 g IN WATER FOR
INJECTION. MAY CONTAIN HCl FOR pH
ADJUSTMENT. ELECTROLYTES PER 1000 mL
(NOT INCLUDING IONS FOR pH ADJUSTMENT):
POTASSIUM 20 mEq; SODIUM 154 mEq;
CHLORIDE 174 mEq.

600 mOsmol/LITER (CALC.)
pH 4.2 (3.5 to 6.5)

ADDITIVES MAY BE INCOMPATIBLE.
CONSULT WITH PHARMACIST, IF
AVAILABLE. WHEN INTRODUCING
ADDITIVES, USE ASEPTIC TECHNIQUE,
MIX THOROUGHLY AND DO NOT STORE.

SINGLE-DOSE CONTAINER. FOR I.V. USE.
USUAL DOSAGE: SEE INSERT. STERILE,
NONPYROGENIC. USE ONLY IF SOLUTION IS
CLEAR AND CONTAINER IS UNDAMAGED. MUST
NOT BE USED IN SERIES CONNECTIONS.

Rx only

3
v
CONTAINS DEHP

IMP0000044
ICU Medical, Inc.,
Lake Forest, Illinois, 60045, USA
icumedical

PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label - IMP0000044
PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label - IMP0000044

PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label - IMP0000045

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

40 mEq POTASSIUM

1000 mL

NDC 0990-7109-09

40
mEq

POTASSIUM
CHLORIDE

in 5% Dextrose and
0.9% Sodium Chloride
Injection, USP

EACH 100 mL CONTAINS POTASSIUM CHLORIDE
298 mg; SODIUM CHLORIDE 900 mg; DEXTROSE,
HYDROUS 5 g IN WATER FOR INJECTION.
MAY CONTAIN HCl FOR pH ADJUSTMENT.
ELECTROLYTES PER 1000 mL (NOT INCLUDING
IONS FOR pH ADJUSTMENT): POTASSIUM
40 mEq; SODIUM 154 mEq; CHLORIDE 194 mEq.

640 mOsmol/LITER (CALC.)
pH 4.2 (3.5 to 6.5)

ADDITIVES MAY BE INCOMPATIBLE. CONSULT
WITH PHARMACIST, IF
AVAILABLE. WHEN INTRODUCING
ADDITIVES, USE ASEPTIC TECHNIQUE,
MIX THOROUGHLY AND DO NOT STORE.

SINGLE-DOSE CONTAINER. FOR I.V. USE.
USUAL DOSAGE: SEE INSERT. STERILE,
NONPYROGENIC. USE ONLY IF SOLUTION IS
CLEAR AND CONTAINER IS UNDAMAGED.
MUST NOT BE USED IN SERIES CONNECTIONS.

Rx ONLY

3
v
CONTAINS DEHP

IMP0000045
ICU Medical, Inc.,
Lake Forest, Illinois, 60045, USA
icumedical

PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label - IMP0000045
PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label - IMP0000045

PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label - IM-4420

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

30 mEq POTASSIUM

1000 mL

NDC 0990-7903-09

30
mEq

POTASSIUM
CHLORIDE

in 5% Dextrose and
0.45% Sodium Chloride
Injection, USP

EACH 100 mL CONTAINS POTASSIUM CHLORIDE
224 mg; SODIUM CHLORIDE 450 mg; DEXTROSE,
HYDROUS 5 g IN WATER FOR INJECTION.
MAY CONTAIN HCl FOR pH ADJUSTMENT.
ELECTROLYTES PER 1000 mL (NOT INCLUDING
IONS FOR pH ADJUSTMENT): POTASSIUM
30 mEq; SODIUM 77 mEq; CHLORIDE 107 mEq.

467 mOsmol/LITER (CALC.)
pH 4.2 (3.5 to 6.5)

ADDITIVES MAY BE INCOMPATIBLE.
CONSULT WITH PHARMACIST, IF
AVAILABLE. WHEN INTRODUCING
ADDITIVES, USE ASEPTIC TECHNIQUE,
MIX THOROUGHLY AND DO NOT STORE.

SINGLE-DOSE CONTAINER. FOR I.V. USE.
USUAL DOSAGE: SEE INSERT. STERILE,
NONPYROGENIC. USE ONLY IF SOLUTION IS
CLEAR AND CONTAINER IS UNDAMAGED.
MUST NOT BE USED IN SERIES CONNECTIONS.

Rx ONLY

3
v
CONTAINS DEHP

IM-4420
ICU Medical, Inc., Lake Forest, Illinois, 60045, USA
icumedical

PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label - IM-4420
PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label - IM-4420

PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label - IM-4421

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

40 mEq POTASSIUM

1000 mL

NDC 0990-7904-09

40
mEq

POTASSIUM
CHLORIDE

in 5% Dextrose and
0.45% Sodium Chloride
Injection, USP

EACH 100 mL CONTAINS POTASSIUM CHLORIDE
298 mg; SODIUM CHLORIDE 450 mg; DEXTROSE,
HYDROUS 5 g IN WATER FOR INJECTION.
MAY CONTAIN HCl FOR pH ADJUSTMENT.
ELECTROLYTES PER 1000 mL (NOT INCLUDING
IONS FOR pH ADJUSTMENT): POTASSIUM
40 mEq; SODIUM 77 mEq; CHLORIDE 117 mEq.

487 mOsmol/LITER (CALC.)
pH 4.2 (3.5 to 6.5)

ADDITIVES MAY BE INCOMPATIBLE.
CONSULT WITH PHARMACIST, IF
AVAILABLE. WHEN INTRODUCING
ADDITIVES, USE ASEPTIC TECHNIQUE,
MIX THOROUGHLY AND DO NOT STORE.

SINGLE-DOSE CONTAINER. FOR I.V. USE.
USUAL DOSAGE: SEE INSERT. STERILE,
NONPYROGENIC. USE ONLY IF SOLUTION IS
CLEAR AND CONTAINER IS UNDAMAGED.
MUST NOT BE USED IN SERIES CONNECTIONS.

Rx ONLY

3
v
CONTAINS DEHP

IM-4421
ICU Medical, Inc., Lake Forest, Illinois, 60045, USA
icumedical

PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label - IM-4421
PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label - IM-4421

PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label - IMP0000057

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

10 mEq POTASSIUM

1000 mL

NDC 0990-7993-09

10
mEq

POTASSIUM
CHLORIDE

in 5% Dextrose and
0.45% Sodium Chloride
Injection, USP

EACH 100 mL CONTAINS POTASSIUM
CHLORIDE 74.5 mg; SODIUM CHLORIDE 450 mg;
DEXTROSE, HYDROUS 5 g IN WATER FOR
INJECTION. MAY CONTAIN HCl FOR pH
ADJUSTMENT.

ELECTROLYTES PER 1000 mL (NOT INCLUDING
IONS FOR pH ADJUSTMENT): POTASSIUM
10 mEq; SODIUM 77 mEq; CHLORIDE 87 mEq.

426 mOsmol/LITER (CALC.)
pH 4.2 (3.5 to 6.5)

ADDITIVES MAY BE INCOMPATIBLE.
CONSULT WITH PHARMACIST, IF AVAILABLE.
WHEN INTRODUCING ADDITIVES,
USE ASEPTIC TECHNIQUE, MIX THOROUGHLY
AND DO NOT STORE.

SINGLE-DOSE CONTAINER. FOR I.V. USE.
USUAL DOSAGE: SEE INSERT. STERILE,
NONPYROGENIC. USE ONLY IF SOLUTION IS
CLEAR AND CONTAINER IS UNDAMAGED.
MUST NOT BE USED IN SERIES CONNECTIONS.

Rx ONLY

3
v
CONTAINS
DEHP

IMP0000057
ICU Medical, Inc.
Lake Forest, Illinois, 60045 USA
icumedical

PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label - IMP0000057
PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label - IMP0000057

PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label - IM-4418

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

20 mEq POTASSIUM

1000 mL

NDC 0990-7901-09

20
mEq

POTASSIUM
CHLORIDE
in 5% Dextrose and
0.225% Sodium Chloride
Injection, USP

EACH 100 mL CONTAINS POTASSIUM CHLORIDE
149 mg; SODIUM CHLORIDE 225 mg; DEXTROSE,
HYDROUS 5 g IN WATER FOR INJECTION.
MAY CONTAIN HCl FOR pH ADJUSTMENT.
ELECTROLYTES PER 1000 mL (NOT INCLUDING
IONS FOR pH ADJUSTMENT): POTASSIUM
20 mEq; SODIUM 38.5 mEq; CHLORIDE 58.5 mEq.

370 mOsmol/LITER (CALC.)
pH 4.2 (3.5 to 6.5)

ADDITIVES MAY BE INCOMPATIBLE.
CONSULT WITH PHARMACIST, IF
AVAILABLE. WHEN INTRODUCING
ADDITIVES, USE ASEPTIC TECHNIQUE,
MIX THOROUGHLY AND DO NOT STORE.

SINGLE-DOSE CONTAINER. FOR I.V. USE.
USUAL DOSAGE: SEE INSERT. STERILE,
NONPYROGENIC. USE ONLY IF SOLUTION IS
CLEAR AND CONTAINER IS UNDAMAGED.
MUST NOT BE USED IN SERIES CONNECTIONS.

©HOSPIRA 2004
IM-0057 (4/04)
PRINTED IN USA
HOSPIRA, INC., LAKE FOREST, IL 60045 USA

Rx ONLY

3
v
CONTAINS DEHP

IM-4418
ICU Medical, Inc., Lake Forest, Illinois, 60045, USA
icumedical

PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label - IM-4418
PRINCIPAL DISPLAY PANEL - 1000 mL Bag Label - IM-4418

PRINCIPAL DISPLAY PANEL - 500 mL Bag Label - IM-4447

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

10 mEq POTASSIUM

500 mL

NDC 0990-7902-03

10
mEq

POTASSIUM
CHLORIDE
in 5% Dextrose and
0.45% Sodium Chloride Inj., USP

EACH 100 mL CONTAINS POTASSIUM CHLORIDE 149 mg;
SODIUM CHLORIDE 450 mg; DEXTROSE, HYDROUS 5 g IN WATER
FOR INJECTION. MAY CONTAIN HCl FOR pH ADJUSTMENT.
ELECTROLYTES PER 1000 mL (NOT INCLUDING IONS FOR pH
ADJUSTMENT): POTASSIUM 20 mEq; SODIUM 77 mEq; CHLORIDE 97 mEq.

447 mOsmol/LITER (CALC.)
pH 4.2 (3.5 to 6.5)

ADDITIVES MAY BE INCOMPATIBLE. CONSULT WITH
PHARMACIST, IF AVAILABLE. WHEN INTRODUCING
ADDITIVES, USE ASEPTIC TECHNIQUE, MIX
THOROUGHLY AND DO NOT STORE.

SINGLE-DOSE CONTAINER. FOR I.V. USE. USUAL DOSAGE: SEE INSERT.
STERILE, NONPYROGENIC. USE ONLY IF SOLUTION IS CLEAR AND CONTAINER
IS UNDAMAGED. MUST NOT BE USED IN SERIES CONNECTIONS.

Rx ONLY

3
v
CONTAINS DEHP

ICU Medical, Inc., Lake Forest, Illinois, 60045, USA
IM-4447
icumedical

PRINCIPAL DISPLAY PANEL - 500 mL Bag Label - IM-4447
PRINCIPAL DISPLAY PANEL - 500 mL Bag Label - IM-4447

PRINCIPAL DISPLAY PANEL - Overwrap

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

TO OPEN TEAR AT NOTCH

2
HDPE

DO NOT REMOVE FROM OVERWRAP UNTIL READY FOR USE. AFTER REMOVING
THE OVERWRAP, CHECK FOR MINUTE LEAKS BY SQUEEZING CONTAINER FIRMLY.
IF LEAKS ARE FOUND, DISCARD SOLUTION AS STERILITY MAY BE IMPAIRED.
RECOMMENDED STORAGE: ROOM TEMPERATURE (25°C). AVOID EXCESSIVE
HEAT. PROTECT FROM FREEZING. SEE INSERT.
98-4321-R14-3/98

PRINCIPAL DISPLAY PANEL - Overwrap
PRINCIPAL DISPLAY PANEL - Overwrap

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
9e37788c-b1bf-42ae-aac9-b60601606144Product name820260122
95250459-30e4-45c1-b08a-993044f49109Product name220250805
d9771140-739b-484b-ae64-b79528ff1211Product name320250801
efd58dcf-540a-4531-8766-e713129ca6f2Product name120250307
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2Product name520250304
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
1527ac37-808d-43be-a63e-74e1258dbe46Product name920250219
a21a21e5-f36d-4c1f-8918-def921b8f7e3Product name320250124
bed0530e-f939-4541-956b-6928a2f6404fProduct name120241008
cefa60e2-a5b5-493e-9c54-24735b7dc509Product name620240814
fb7ab793-2c12-4079-b100-a64f73bef25aProduct name420240712
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
b0cbf770-6cc3-4aa4-9158-755110c2b9f7Product name220230717
cb89b86a-369e-4204-8910-ae797c503af3Product name120230706
dc7c5daa-021f-40dd-b00d-63982cb2067aProduct name120230426
9fcb7a91-de07-4f00-aabf-e4d6fda403d5Product name820230322
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
9badc7be-250a-44ab-aa36-926af3f02679Product name120210527
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name520200925
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
0ec3537a-6c9b-432a-896c-b9ea8723049aProduct name920200701
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
d4880ace-a516-8c47-8dfd-73a4ba5887d7Product name220180830
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
7916de40-e296-41f0-b811-6d0df1a33e2cProduct name920180627
cefa60e2-a5b5-493e-9c54-24735b7dc509Product name220171212
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
26acd337-b838-40ac-bcbc-05c3b81c8712Product name120170323
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name220160823
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0990-7107-09ML - Milliliter0990-71075fd23d3c-8090-459e-a96d-2ca46cfd089112020-07-13
0990-7109-09ML - Milliliter0990-7109c6815c56-5351-4090-ab37-f5c497af624912020-03-10
0990-7903-09ML - Milliliter0990-79033f1c7400-c7fb-40ca-a16c-5bbd9af38c9112021-01-08
0990-7904-09ML - Milliliter0990-79042125bc8f-6861-4fc5-ba8c-3c62cace639812020-05-08
0990-7993-09ML - Milliliter0990-7993d48ed5a6-0651-4a78-a871-9bf3f4652e2412021-01-08
0990-7901-09ML - Milliliter0990-79012cc35b2e-f1ed-4aa4-9c20-44fc8500b00912020-08-06
0990-7902-09ML - Milliliter0990-790273de4f5e-7531-48ba-b3b0-c3dd0f5c4fda12020-04-20

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 35 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
172025-11-02full-release2026-05-31 22:03:54
142021-10-18full-release2026-05-31 20:55:50

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 3 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 9 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N018362-002POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;224MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982
N018362-003POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;298MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982
N018362-004POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;149MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-28
N018362-005POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;149MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS1988-03-28
N018362-006POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;224MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-28
N018362-007POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;298MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-28
N018362-008POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;74.5MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-28
N018362-009POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;74.5MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS1983-07-05
N018362-010POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;149MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS1983-07-05

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 5 matching rows.

Application-product, TE code table
Application-productTE code
N018362-002AP
N018362-003AP
N018362-005AP
N018362-009AP
N018362-010AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 11 · 405 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N018362-002POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982d4dbc9d85df4…
2026-11-14 07:37:172026-10N018362-003POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982d4dbc9d85df4…
2026-11-14 07:37:172026-10N018362-004POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-28d4dbc9d85df4…
2026-11-14 07:37:172026-10N018362-005POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS1988-03-28d4dbc9d85df4…
2026-11-14 07:37:172026-10N018362-006POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-28d4dbc9d85df4…
2026-11-14 07:37:172026-10N018362-007POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-28d4dbc9d85df4…
2026-11-14 07:37:172026-10N018362-008POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-28d4dbc9d85df4…
2026-11-14 07:37:172026-10N018362-009POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS1983-07-05d4dbc9d85df4…
2026-11-14 07:37:172026-10N018362-010POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS1983-07-05d4dbc9d85df4…
2026-10-15 13:18:302026-09N018362-002POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982c2088c7a36db…
2026-10-15 13:18:302026-09N018362-003POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982c2088c7a36db…
2026-10-15 13:18:302026-09N018362-004POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-28c2088c7a36db…
2026-10-15 13:18:302026-09N018362-005POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS1988-03-28c2088c7a36db…
2026-10-15 13:18:302026-09N018362-006POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-28c2088c7a36db…
2026-10-15 13:18:302026-09N018362-007POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-28c2088c7a36db…
2026-10-15 13:18:302026-09N018362-008POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-28c2088c7a36db…
2026-10-15 13:18:302026-09N018362-009POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS1983-07-05c2088c7a36db…
2026-10-15 13:18:302026-09N018362-010POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS1983-07-05c2088c7a36db…
2026-09-14 22:38:342026-08N018362-002POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS, Approved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N018362-003POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS, Approved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N018362-004POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-2884e616aacf4f…
2026-09-14 22:38:342026-08N018362-005POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS1988-03-2884e616aacf4f…
2026-09-14 22:38:342026-08N018362-006POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-2884e616aacf4f…
2026-09-14 22:38:342026-08N018362-007POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-2884e616aacf4f…
2026-09-14 22:38:342026-08N018362-008POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-2884e616aacf4f…
2026-09-14 22:38:342026-08N018362-009POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS1983-07-0584e616aacf4f…
2026-09-14 22:38:342026-08N018362-010POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS1983-07-0584e616aacf4f…
2026-08-18 06:07:402026-07N018362-002POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982caaa826d4ba7…
2026-08-18 06:07:402026-07N018362-003POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982caaa826d4ba7…
2026-08-18 06:07:402026-07N018362-004POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-28caaa826d4ba7…
2026-08-18 06:07:402026-07N018362-005POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS1988-03-28caaa826d4ba7…
2026-08-18 06:07:402026-07N018362-006POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-28caaa826d4ba7…
2026-08-18 06:07:402026-07N018362-007POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-28caaa826d4ba7…
2026-08-18 06:07:402026-07N018362-008POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-28caaa826d4ba7…
2026-08-18 06:07:402026-07N018362-009POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS1983-07-05caaa826d4ba7…
2026-08-18 06:07:402026-07N018362-010POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS1983-07-05caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N018362-002POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N018362-003POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N018362-004POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;450MG/100MLINJECTABLE / INJECTIONRLD1988-03-28011fe1cb6892…
2026-02-19 14:30 UTC2026-02N018362-005POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;450MG/100MLINJECTABLE / INJECTIONAPRLD, RS1988-03-28011fe1cb6892…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 6 · 225 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10N018362-002AP1d4dbc9d85df4…
2026-11-14 07:37:172026-10N018362-003AP1d4dbc9d85df4…
2026-11-14 07:37:172026-10N018362-005AP1d4dbc9d85df4…
2026-11-14 07:37:172026-10N018362-009AP1d4dbc9d85df4…
2026-11-14 07:37:172026-10N018362-010AP1d4dbc9d85df4…
2026-10-15 13:18:302026-09N018362-002AP1c2088c7a36db…
2026-10-15 13:18:302026-09N018362-003AP1c2088c7a36db…
2026-10-15 13:18:302026-09N018362-005AP1c2088c7a36db…
2026-10-15 13:18:302026-09N018362-009AP1c2088c7a36db…
2026-10-15 13:18:302026-09N018362-010AP1c2088c7a36db…
2026-09-14 22:38:342026-08N018362-002AP184e616aacf4f…
2026-09-14 22:38:342026-08N018362-003AP184e616aacf4f…
2026-09-14 22:38:342026-08N018362-005AP184e616aacf4f…
2026-09-14 22:38:342026-08N018362-009AP184e616aacf4f…
2026-09-14 22:38:342026-08N018362-010AP184e616aacf4f…
2026-08-18 06:07:402026-07N018362-002AP1caaa826d4ba7…
2026-08-18 06:07:402026-07N018362-003AP1caaa826d4ba7…
2026-08-18 06:07:402026-07N018362-005AP1caaa826d4ba7…
2026-08-18 06:07:402026-07N018362-009AP1caaa826d4ba7…
2026-08-18 06:07:402026-07N018362-010AP1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N018362-002AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N018362-003AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N018362-005AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N018362-009AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N018362-010AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N018362-002AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N018362-003AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N018362-005AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N018362-009AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N018362-010AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08N018362-002AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N018362-003AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N018362-005AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N018362-009AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N018362-010AP16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N018362-002AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N018362-003AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N018362-005AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N018362-009AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N018362-010AP1fd3edfee7708…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 9 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N018365-001POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;149MG/100ML;225MG/100MLINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982
N018365-002POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;74.5MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD1983-07-05
N018365-003POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;224MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1983-07-05
N018365-004POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;298MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1983-07-05
N018365-005POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;74.5MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1988-03-28
N018365-006POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;149MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD1988-03-28
N018365-007POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;149MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1988-03-28
N018365-008POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;224MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1988-03-28
N018365-009POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;298MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD1988-03-28

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
N018365-001AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 11 · 405 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N018365-001POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;225MG/100MLINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982d4dbc9d85df4…
2026-11-14 07:37:172026-10N018365-002POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD1983-07-05d4dbc9d85df4…
2026-11-14 07:37:172026-10N018365-003POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1983-07-05d4dbc9d85df4…
2026-11-14 07:37:172026-10N018365-004POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1983-07-05d4dbc9d85df4…
2026-11-14 07:37:172026-10N018365-005POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1988-03-28d4dbc9d85df4…
2026-11-14 07:37:172026-10N018365-006POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD1988-03-28d4dbc9d85df4…
2026-11-14 07:37:172026-10N018365-007POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1988-03-28d4dbc9d85df4…
2026-11-14 07:37:172026-10N018365-008POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1988-03-28d4dbc9d85df4…
2026-11-14 07:37:172026-10N018365-009POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD1988-03-28d4dbc9d85df4…
2026-10-15 13:18:302026-09N018365-001POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;225MG/100MLINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982c2088c7a36db…
2026-10-15 13:18:302026-09N018365-002POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD1983-07-05c2088c7a36db…
2026-10-15 13:18:302026-09N018365-003POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1983-07-05c2088c7a36db…
2026-10-15 13:18:302026-09N018365-004POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1983-07-05c2088c7a36db…
2026-10-15 13:18:302026-09N018365-005POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1988-03-28c2088c7a36db…
2026-10-15 13:18:302026-09N018365-006POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD1988-03-28c2088c7a36db…
2026-10-15 13:18:302026-09N018365-007POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1988-03-28c2088c7a36db…
2026-10-15 13:18:302026-09N018365-008POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1988-03-28c2088c7a36db…
2026-10-15 13:18:302026-09N018365-009POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD1988-03-28c2088c7a36db…
2026-09-14 22:38:342026-08N018365-001POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;225MG/100MLINJECTABLE / INJECTIONAPRLD, RS, Approved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N018365-002POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD1983-07-0584e616aacf4f…
2026-09-14 22:38:342026-08N018365-003POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1983-07-0584e616aacf4f…
2026-09-14 22:38:342026-08N018365-004POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1983-07-0584e616aacf4f…
2026-09-14 22:38:342026-08N018365-005POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1988-03-2884e616aacf4f…
2026-09-14 22:38:342026-08N018365-006POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD1988-03-2884e616aacf4f…
2026-09-14 22:38:342026-08N018365-007POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1988-03-2884e616aacf4f…
2026-09-14 22:38:342026-08N018365-008POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1988-03-2884e616aacf4f…
2026-09-14 22:38:342026-08N018365-009POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD1988-03-2884e616aacf4f…
2026-08-18 06:07:402026-07N018365-001POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;225MG/100MLINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982caaa826d4ba7…
2026-08-18 06:07:402026-07N018365-002POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD1983-07-05caaa826d4ba7…
2026-08-18 06:07:402026-07N018365-003POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1983-07-05caaa826d4ba7…
2026-08-18 06:07:402026-07N018365-004POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1983-07-05caaa826d4ba7…
2026-08-18 06:07:402026-07N018365-005POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1988-03-28caaa826d4ba7…
2026-08-18 06:07:402026-07N018365-006POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD1988-03-28caaa826d4ba7…
2026-08-18 06:07:402026-07N018365-007POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1988-03-28caaa826d4ba7…
2026-08-18 06:07:402026-07N018365-008POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1988-03-28caaa826d4ba7…
2026-08-18 06:07:402026-07N018365-009POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD1988-03-28caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N018365-001POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;225MG/100MLINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N018365-002POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD1983-07-05011fe1cb6892…
2026-02-19 14:30 UTC2026-02N018365-003POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1983-07-05011fe1cb6892…
2026-02-19 14:30 UTC2026-02N018365-004POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTION1983-07-05011fe1cb6892…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10N018365-001AP1d4dbc9d85df4…
2026-10-15 13:18:302026-09N018365-001AP1c2088c7a36db…
2026-09-14 22:38:342026-08N018365-001AP184e616aacf4f…
2026-08-18 06:07:402026-07N018365-001AP1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N018365-001AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N018365-001AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08N018365-001AP16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N018365-001AP1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N018365-001AP1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N018365-001AP103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N018365-001AP12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N018365-001AP15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N018365-001AP1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N018365-001AP1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N018365-001AP179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N018365-001AP1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N018365-001AP11e350fbaab3a…
2024-05-31 18:47 UTC2024-05N018365-001AP18072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N018365-001AP16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N018365-001AP11c564ffb4f44…
2023-12-20 04:57 UTC2023-12N018365-001AP1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N018365-001AP1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N018365-001AP19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N018365-001AP1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N018365-001AP13f0d92c62455…
2023-05-13 08:27 UTC2023-05N018365-001AP1053a50430f4f…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N018365-001AP1a50c72e98297…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 9 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N019691-001POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;74.5MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24
N019691-002POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;74.5MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24
N019691-003POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;149MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24
N019691-004POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;149MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24
N019691-005POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;149MG/100ML;900MG/100MLINJECTABLE / INJECTIONAPRLD, RS1988-03-24
N019691-006POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;224MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24
N019691-007POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;224MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24
N019691-008POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;298MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24
N019691-009POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE5GM/100ML;298MG/100ML;900MG/100MLINJECTABLE / INJECTIONAPRLD, RS1988-03-24

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
N019691-005AP
N019691-009AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 11 · 405 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N019691-001POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24d4dbc9d85df4…
2026-11-14 07:37:172026-10N019691-002POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24d4dbc9d85df4…
2026-11-14 07:37:172026-10N019691-003POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24d4dbc9d85df4…
2026-11-14 07:37:172026-10N019691-004POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24d4dbc9d85df4…
2026-11-14 07:37:172026-10N019691-005POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;900MG/100MLINJECTABLE / INJECTIONAPRLD, RS1988-03-24d4dbc9d85df4…
2026-11-14 07:37:172026-10N019691-006POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24d4dbc9d85df4…
2026-11-14 07:37:172026-10N019691-007POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24d4dbc9d85df4…
2026-11-14 07:37:172026-10N019691-008POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24d4dbc9d85df4…
2026-11-14 07:37:172026-10N019691-009POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;900MG/100MLINJECTABLE / INJECTIONAPRLD, RS1988-03-24d4dbc9d85df4…
2026-10-15 13:18:302026-09N019691-001POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24c2088c7a36db…
2026-10-15 13:18:302026-09N019691-002POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24c2088c7a36db…
2026-10-15 13:18:302026-09N019691-003POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24c2088c7a36db…
2026-10-15 13:18:302026-09N019691-004POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24c2088c7a36db…
2026-10-15 13:18:302026-09N019691-005POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;900MG/100MLINJECTABLE / INJECTIONAPRLD, RS1988-03-24c2088c7a36db…
2026-10-15 13:18:302026-09N019691-006POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24c2088c7a36db…
2026-10-15 13:18:302026-09N019691-007POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24c2088c7a36db…
2026-10-15 13:18:302026-09N019691-008POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24c2088c7a36db…
2026-10-15 13:18:302026-09N019691-009POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;900MG/100MLINJECTABLE / INJECTIONAPRLD, RS1988-03-24c2088c7a36db…
2026-09-14 22:38:342026-08N019691-001POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-2484e616aacf4f…
2026-09-14 22:38:342026-08N019691-002POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-2484e616aacf4f…
2026-09-14 22:38:342026-08N019691-003POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-2484e616aacf4f…
2026-09-14 22:38:342026-08N019691-004POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-2484e616aacf4f…
2026-09-14 22:38:342026-08N019691-005POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;900MG/100MLINJECTABLE / INJECTIONAPRLD, RS1988-03-2484e616aacf4f…
2026-09-14 22:38:342026-08N019691-006POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-2484e616aacf4f…
2026-09-14 22:38:342026-08N019691-007POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-2484e616aacf4f…
2026-09-14 22:38:342026-08N019691-008POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-2484e616aacf4f…
2026-09-14 22:38:342026-08N019691-009POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;900MG/100MLINJECTABLE / INJECTIONAPRLD, RS1988-03-2484e616aacf4f…
2026-08-18 06:07:402026-07N019691-001POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24caaa826d4ba7…
2026-08-18 06:07:402026-07N019691-002POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24caaa826d4ba7…
2026-08-18 06:07:402026-07N019691-003POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24caaa826d4ba7…
2026-08-18 06:07:402026-07N019691-004POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24caaa826d4ba7…
2026-08-18 06:07:402026-07N019691-005POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;900MG/100MLINJECTABLE / INJECTIONAPRLD, RS1988-03-24caaa826d4ba7…
2026-08-18 06:07:402026-07N019691-006POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24caaa826d4ba7…
2026-08-18 06:07:402026-07N019691-007POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;224MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24caaa826d4ba7…
2026-08-18 06:07:402026-07N019691-008POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24caaa826d4ba7…
2026-08-18 06:07:402026-07N019691-009POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;298MG/100ML;900MG/100MLINJECTABLE / INJECTIONAPRLD, RS1988-03-24caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N019691-001POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N019691-002POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;74.5MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N019691-003POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N019691-004POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER5GM/100ML;149MG/100ML;900MG/100MLINJECTABLE / INJECTIONRLD1988-03-24011fe1cb6892…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 90 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10N019691-005AP1d4dbc9d85df4…
2026-11-14 07:37:172026-10N019691-009AP1d4dbc9d85df4…
2026-10-15 13:18:302026-09N019691-005AP1c2088c7a36db…
2026-10-15 13:18:302026-09N019691-009AP1c2088c7a36db…
2026-09-14 22:38:342026-08N019691-005AP184e616aacf4f…
2026-09-14 22:38:342026-08N019691-009AP184e616aacf4f…
2026-08-18 06:07:402026-07N019691-005AP1caaa826d4ba7…
2026-08-18 06:07:402026-07N019691-009AP1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N019691-005AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N019691-009AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N019691-005AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N019691-009AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08N019691-005AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N019691-009AP16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N019691-005AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N019691-009AP1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N019691-005AP1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N019691-009AP1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N019691-005AP103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N019691-009AP103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N019691-005AP12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N019691-009AP12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N019691-005AP15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N019691-009AP15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N019691-005AP1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N019691-009AP1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N019691-005AP1d06236e962d9…
2024-10-29 15:01 UTC2024-10N019691-009AP1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N019691-005AP179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N019691-009AP179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N019691-005AP1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N019691-009AP1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N019691-005AP11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N019691-009AP11e350fbaab3a…
2024-05-31 18:47 UTC2024-05N019691-005AP18072bd15b7f6…
2024-05-31 18:47 UTC2024-05N019691-009AP18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N019691-005AP15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N019691-009AP15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N019691-005AP15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N019691-009AP15d02ea3f76ae…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Potassium Chloride in Dextrose and Sodium ChlorideDEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDEICU Medical Inc.d8ee14e9-6733-4813-9f21-2b043a5f71882025-11-02Warnings, Adverse reactionsExact identifier
ndc (package): 0990-7993-09
ndc (package): 0990-7107-09
ndc (package): 0990-7109-09
ndc (package): 0990-7903-09
ndc (package): 0990-7902-03
ndc (package): 0990-7901-09
ndc (package): 0990-7904-09
ndc (package): 0990-7902-09
ndc (product): 0990-7903
ndc (product): 0990-7107
ndc (product): 0990-7993
ndc (product): 0990-7904
ndc (product): 0990-7109
ndc (product): 0990-7901
ndc (product): 0990-7902
ndc11 (package): 00990790209
ndc11 (package): 00990710909
ndc11 (package): 00990799309
ndc11 (package): 00990710709
ndc11 (package): 00990790203
ndc11 (package): 00990790109
ndc11 (package): 00990790409
ndc11 (package): 00990790309
spl id: 11a3a5e5-57e6-49b9-bed9-c4db277a38be
spl set id: d8ee14e9-6733-4813-9f21-2b043a5f7188

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.